Concepedia

Yuichiro Tada

YT

47

Publications

2K

Citations

26

H-Index

1994

Active since

Affiliations

Mita Hospital(Current)

Tokyo Medical University

Nagoya City University

Hokkaido University

Fujita Health University

Yuichiro Tada is an author at Mita Hospital specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

1994–2024

47

Publications

47

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma

Hideaki Takahashi, Yuichiro Tada, Takashi Saotome et al. · Journal of Clinical Oncology · 2018 · 246 citations

A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma

C. Fushimi, Yuichiro Tada, Hideaki Takahashi et al. · Annals of Oncology · 2017 · 211 citations · Full text

Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma

Tatsuo Masubuchi, Yuichiro Tada, Shin-ichiro Maruya et al. · International Journal of Clinical Oncology · 2014 · 114 citations

, , +9

Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification

Soichiro Takase, Satoshi Kano, Yuichiro Tada et al. · Oncotarget · 2017 · 110 citations · Full text

Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients

Kuninori Otsuka, Yorihisa Imanishi, Yuichiro Tada et al. · Annals of Surgical Oncology · 2016 · 104 citations · Full text

Rows per page

1–5 of 47